Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy

Heart failure is a major cause of morbidity and mortality worldwide. Here the authors show that subcutaneous administration of antisense oligonucleotides targeting PLN is an effective strategy in preclinical models of genetic cardiomyopathy and ischemia-driven heart failure.

Guardado en:
Detalles Bibliográficos
Autores principales: Niels Grote Beverborg, Daniela Später, Ralph Knöll, Alejandro Hidalgo, Steve T. Yeh, Zaher Elbeck, Herman H. W. Silljé, Tim R. Eijgenraam, Humam Siga, Magdalena Zurek, Malin Palmér, Susanne Pehrsson, Tamsin Albery, Nils Bomer, Martijn F. Hoes, Cornelis J. Boogerd, Michael Frisk, Eva van Rooij, Sagar Damle, William E. Louch, Qing-Dong Wang, Regina Fritsche-Danielson, Kenneth R. Chien, Kenny M. Hansson, Adam E. Mullick, Rudolf A. de Boer, Peter van der Meer
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/fe3711b0c9be44609d25d2ed5e1f2344
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fe3711b0c9be44609d25d2ed5e1f2344
record_format dspace
spelling oai:doaj.org-article:fe3711b0c9be44609d25d2ed5e1f23442021-12-02T19:04:19ZPhospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy10.1038/s41467-021-25439-02041-1723https://doaj.org/article/fe3711b0c9be44609d25d2ed5e1f23442021-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-25439-0https://doaj.org/toc/2041-1723Heart failure is a major cause of morbidity and mortality worldwide. Here the authors show that subcutaneous administration of antisense oligonucleotides targeting PLN is an effective strategy in preclinical models of genetic cardiomyopathy and ischemia-driven heart failure.Niels Grote BeverborgDaniela SpäterRalph KnöllAlejandro HidalgoSteve T. YehZaher ElbeckHerman H. W. SilljéTim R. EijgenraamHumam SigaMagdalena ZurekMalin PalmérSusanne PehrssonTamsin AlberyNils BomerMartijn F. HoesCornelis J. BoogerdMichael FriskEva van RooijSagar DamleWilliam E. LouchQing-Dong WangRegina Fritsche-DanielsonKenneth R. ChienKenny M. HanssonAdam E. MullickRudolf A. de BoerPeter van der MeerNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-15 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Niels Grote Beverborg
Daniela Später
Ralph Knöll
Alejandro Hidalgo
Steve T. Yeh
Zaher Elbeck
Herman H. W. Silljé
Tim R. Eijgenraam
Humam Siga
Magdalena Zurek
Malin Palmér
Susanne Pehrsson
Tamsin Albery
Nils Bomer
Martijn F. Hoes
Cornelis J. Boogerd
Michael Frisk
Eva van Rooij
Sagar Damle
William E. Louch
Qing-Dong Wang
Regina Fritsche-Danielson
Kenneth R. Chien
Kenny M. Hansson
Adam E. Mullick
Rudolf A. de Boer
Peter van der Meer
Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy
description Heart failure is a major cause of morbidity and mortality worldwide. Here the authors show that subcutaneous administration of antisense oligonucleotides targeting PLN is an effective strategy in preclinical models of genetic cardiomyopathy and ischemia-driven heart failure.
format article
author Niels Grote Beverborg
Daniela Später
Ralph Knöll
Alejandro Hidalgo
Steve T. Yeh
Zaher Elbeck
Herman H. W. Silljé
Tim R. Eijgenraam
Humam Siga
Magdalena Zurek
Malin Palmér
Susanne Pehrsson
Tamsin Albery
Nils Bomer
Martijn F. Hoes
Cornelis J. Boogerd
Michael Frisk
Eva van Rooij
Sagar Damle
William E. Louch
Qing-Dong Wang
Regina Fritsche-Danielson
Kenneth R. Chien
Kenny M. Hansson
Adam E. Mullick
Rudolf A. de Boer
Peter van der Meer
author_facet Niels Grote Beverborg
Daniela Später
Ralph Knöll
Alejandro Hidalgo
Steve T. Yeh
Zaher Elbeck
Herman H. W. Silljé
Tim R. Eijgenraam
Humam Siga
Magdalena Zurek
Malin Palmér
Susanne Pehrsson
Tamsin Albery
Nils Bomer
Martijn F. Hoes
Cornelis J. Boogerd
Michael Frisk
Eva van Rooij
Sagar Damle
William E. Louch
Qing-Dong Wang
Regina Fritsche-Danielson
Kenneth R. Chien
Kenny M. Hansson
Adam E. Mullick
Rudolf A. de Boer
Peter van der Meer
author_sort Niels Grote Beverborg
title Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy
title_short Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy
title_full Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy
title_fullStr Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy
title_full_unstemmed Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy
title_sort phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/fe3711b0c9be44609d25d2ed5e1f2344
work_keys_str_mv AT nielsgrotebeverborg phospholambanantisenseoligonucleotidesimprovecardiacfunctioninmurinecardiomyopathy
AT danielaspater phospholambanantisenseoligonucleotidesimprovecardiacfunctioninmurinecardiomyopathy
AT ralphknoll phospholambanantisenseoligonucleotidesimprovecardiacfunctioninmurinecardiomyopathy
AT alejandrohidalgo phospholambanantisenseoligonucleotidesimprovecardiacfunctioninmurinecardiomyopathy
AT stevetyeh phospholambanantisenseoligonucleotidesimprovecardiacfunctioninmurinecardiomyopathy
AT zaherelbeck phospholambanantisenseoligonucleotidesimprovecardiacfunctioninmurinecardiomyopathy
AT hermanhwsillje phospholambanantisenseoligonucleotidesimprovecardiacfunctioninmurinecardiomyopathy
AT timreijgenraam phospholambanantisenseoligonucleotidesimprovecardiacfunctioninmurinecardiomyopathy
AT humamsiga phospholambanantisenseoligonucleotidesimprovecardiacfunctioninmurinecardiomyopathy
AT magdalenazurek phospholambanantisenseoligonucleotidesimprovecardiacfunctioninmurinecardiomyopathy
AT malinpalmer phospholambanantisenseoligonucleotidesimprovecardiacfunctioninmurinecardiomyopathy
AT susannepehrsson phospholambanantisenseoligonucleotidesimprovecardiacfunctioninmurinecardiomyopathy
AT tamsinalbery phospholambanantisenseoligonucleotidesimprovecardiacfunctioninmurinecardiomyopathy
AT nilsbomer phospholambanantisenseoligonucleotidesimprovecardiacfunctioninmurinecardiomyopathy
AT martijnfhoes phospholambanantisenseoligonucleotidesimprovecardiacfunctioninmurinecardiomyopathy
AT cornelisjboogerd phospholambanantisenseoligonucleotidesimprovecardiacfunctioninmurinecardiomyopathy
AT michaelfrisk phospholambanantisenseoligonucleotidesimprovecardiacfunctioninmurinecardiomyopathy
AT evavanrooij phospholambanantisenseoligonucleotidesimprovecardiacfunctioninmurinecardiomyopathy
AT sagardamle phospholambanantisenseoligonucleotidesimprovecardiacfunctioninmurinecardiomyopathy
AT williamelouch phospholambanantisenseoligonucleotidesimprovecardiacfunctioninmurinecardiomyopathy
AT qingdongwang phospholambanantisenseoligonucleotidesimprovecardiacfunctioninmurinecardiomyopathy
AT reginafritschedanielson phospholambanantisenseoligonucleotidesimprovecardiacfunctioninmurinecardiomyopathy
AT kennethrchien phospholambanantisenseoligonucleotidesimprovecardiacfunctioninmurinecardiomyopathy
AT kennymhansson phospholambanantisenseoligonucleotidesimprovecardiacfunctioninmurinecardiomyopathy
AT adamemullick phospholambanantisenseoligonucleotidesimprovecardiacfunctioninmurinecardiomyopathy
AT rudolfadeboer phospholambanantisenseoligonucleotidesimprovecardiacfunctioninmurinecardiomyopathy
AT petervandermeer phospholambanantisenseoligonucleotidesimprovecardiacfunctioninmurinecardiomyopathy
_version_ 1718377245863575552